McKesson Co. (MCK) Shares Sold by Whittier Trust Co.
Whittier Trust Co. cut its holdings in McKesson Co. (NYSE:MCK) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 61,588 shares of the company’s stock after selling 1,224 shares during the period. Whittier Trust Co.’s holdings in McKesson were worth $9,604,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also bought and sold shares of the company. KBC Group NV grew its stake in shares of McKesson by 16.4% in the 4th quarter. KBC Group NV now owns 232,919 shares of the company’s stock valued at $36,324,000 after buying an additional 32,859 shares during the period. California Public Employees Retirement System grew its stake in shares of McKesson by 3.2% in the 4th quarter. California Public Employees Retirement System now owns 527,243 shares of the company’s stock valued at $82,224,000 after buying an additional 16,549 shares during the period. Rench Wealth Management Inc. acquired a new stake in shares of McKesson in the 4th quarter valued at about $456,000. River Road Asset Management LLC grew its stake in shares of McKesson by 23.2% in the 4th quarter. River Road Asset Management LLC now owns 13,174 shares of the company’s stock valued at $2,054,000 after buying an additional 2,482 shares during the period. Finally, ING Groep NV grew its stake in shares of McKesson by 732.0% in the 4th quarter. ING Groep NV now owns 17,622 shares of the company’s stock valued at $2,748,000 after buying an additional 15,504 shares during the period. 88.03% of the stock is owned by hedge funds and other institutional investors.
In other McKesson news, Chairman John H. Hammergren sold 65,000 shares of McKesson stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $160.00, for a total transaction of $10,400,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.20% of the stock is currently owned by insiders.
McKesson Co. (NYSE:MCK) opened at $148.93 on Friday. The stock has a market capitalization of $30,730.07, a PE ratio of 11.88, a price-to-earnings-growth ratio of 1.35 and a beta of 1.23. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.61 and a current ratio of 1.07. McKesson Co. has a 12 month low of $133.82 and a 12 month high of $178.86.
McKesson (NYSE:MCK) last released its quarterly earnings results on Thursday, February 1st. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.92 by $0.49. The business had revenue of $53.62 billion during the quarter, compared to the consensus estimate of $51.98 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.04 EPS. equities research analysts expect that McKesson Co. will post 12.69 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 1st will be paid a dividend of $0.34 per share. The ex-dividend date is Wednesday, February 28th. This represents a $1.36 dividend on an annualized basis and a yield of 0.91%. McKesson’s dividend payout ratio (DPR) is currently 6.03%.
WARNING: “McKesson Co. (MCK) Shares Sold by Whittier Trust Co.” was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/mckesson-co-mck-shares-sold-by-whittier-trust-co/1859741.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.